Protective and Pathological Immune Responses in L. Braziliensis Infection

巴西乳杆菌感染的保护性和病理性免疫反应

基本信息

  • 批准号:
    8501131
  • 负责人:
  • 金额:
    $ 10.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-08-01 至 2017-07-31
  • 项目状态:
    已结题

项目摘要

The major hypothesis of this project is that the control of leishmaniasis in individuals with sub-clinical L.braziliensis infection is performed by innate immune response and that skin associated cytokines and CD8+ T cells participate of tissue damage leading development of cutaneous leishmaniasis (CL), mucosal leishmaniasis and disseminated leishmaniasis (DL). The major aims are: Aimi) To determine how innate cells control L. braziliensis parasites. Our finding that a large number of individuals (subclinical) who are infected by L.braziliensis will control the parasites without developing disease provides a unique opportunity to define how natural resistance may be occurring to L.braziliensis. We propose to: a) define the mechanism(s) involved in the killing of parasites by neutrophils and macrophages; b) determine if neutrophils and macrophages from patients with different forms ofthe disease exhibit differences in their capacity to kill parasites; Aim2) To determine what skin-associated cytokines contribute to the pathologic responses following L. braziliensis infecfion. We found that thymic stromal lymphopoietin (TSLP), a cytokine produced by epithelial cells at barrier surfaces, is highly expressed in the epidermis of lesions from CL pafients. We propose to: a) determine the effect of TSLP in macrophage and dendritic cells (DCs) infected with L. braziliensis; b) determine the role of TSLP in CD4+ T and CD8+ T cell proliferation and funcfion; and c) correlate the expression of TSLP in lesions from different clinical phenotypes with T cell function. Aim3) To determine how CD8 T cells participate in the immunopathology in patients infected with L. braziliensis. Since our preliminary data indicate that CD8 T cells exhibit increased levels of granzyme as the lesions worsen, we hypothesize that CD8 T cells contribute to the pathology seen in patients, and propose to: a) determine the mechanisms involved in the recruitment of CD8+ T cells to cutaneous lesion sites; b) determine the frequency and the balance of inflammatory versus regulatory CD8+ T cell subpopulations in the blood and lesions from CL patients; and c) compare the ability of CD8+ T cells from SC individuals and CL patients to promote killing of L. braziliensis infected macrophages in vitro.
该项目的主要假设是,亚临床利什曼病患者的控制 巴西乳杆菌感染是通过先天免疫应答进行的,皮肤相关的细胞因子和 CD 8 + T细胞参与导致皮肤利什曼病(CL)、粘膜利什曼病(CL)、 利什曼病和播散性利什曼病(DL)。主要目的是:艾米)为了确定如何先天 细胞对照L.巴西寄生虫我们发现,大量的人(亚临床)谁是 感染巴西乳杆菌的人将控制寄生虫而不发展疾病提供了一个独特的机会 来确定巴西乳杆菌的天然耐药性是如何产生的。我们建议:a)界定 参与嗜中性粒细胞和巨噬细胞杀死寄生虫的机制; B)确定嗜中性粒细胞是否 而来自不同疾病患者的巨噬细胞在杀伤能力上表现出差异 目的2)确定哪些皮肤相关细胞因子参与病理反应 关注L.巴西侵染我们发现,胸腺基质淋巴细胞生成素(TSLP),一种细胞因子, 由屏障表面的上皮细胞表达,在CL患者病变的表皮中高度表达。我们 本研究拟:a)测定TSLP对感染L. B)确定TSLP在CD 4 + T和CD 8 + T细胞增殖和功能中的作用;和c) TSLP在不同临床表型的病变中的表达与T细胞功能相关。目标3) 确定CD 8 T细胞如何参与感染L.巴西。以来 我们的初步数据表明,随着病变的恶化,CD 8 T细胞表现出颗粒酶水平的增加, 假设CD 8 T细胞对患者中所见的病理有贡献,并提出:a)确定 涉及将CD 8 + T细胞募集到皮肤损伤部位的机制; B)确定 血液中炎性与调节性CD 8 + T细胞亚群的频率和平衡, c)比较来自SC个体和CL患者的CD 8 + T细胞与来自SC个体和CL患者的CD 8 + T细胞的能力, 促进L. braziliensis感染的巨噬细胞。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Edgar M Carvalho其他文献

Immunological and viral features in patients with overactive bladder indicate an early stage of myelopathy
  • DOI:
    10.1186/1742-4690-8-s1-a116
  • 发表时间:
    2011-06-06
  • 期刊:
  • 影响因子:
    3.900
  • 作者:
    Silvane B Santos;Paulo Oliveira;Matheus Tannus;Tania Luna;Anselmo Souza;Thais Delavechia;Márcia Nascimento;Glória Orge;Isadora Siqueira;Davi Tanajura;André Luiz Muniz;Marshall J Glesby;Edgar M Carvalho
  • 通讯作者:
    Edgar M Carvalho
Does helminthic infection alter the clinical course of HTLV-1 infection?
  • DOI:
    10.1186/1742-4690-8-s1-a47
  • 发表时间:
    2011-06-06
  • 期刊:
  • 影响因子:
    3.900
  • 作者:
    Michael A Sundberg;Marshall J Glesby;Edgar M Carvalho
  • 通讯作者:
    Edgar M Carvalho
Prevalence and influence of tuberculosis in the neurologic manifestations of the Human T cell lymphotropic virus type 1 (HTLV-1)
结核病对人类 T 细胞嗜淋巴细胞病毒 1 型 (HTLV-1) 神经系统表现的影响
  • DOI:
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    3.3
  • 作者:
    Maria de Lourdes Bastos;Anselmo S Souza;N. Carvalho;Yuri Neves;S. Santos;Edgar M Carvalho
  • 通讯作者:
    Edgar M Carvalho
Influence of HTLV-1 in the clinic, microbiologic and immunologic features of tuberculosis
  • DOI:
    10.1186/1742-4690-8-s1-a45
  • 发表时间:
    2011-06-06
  • 期刊:
  • 影响因子:
    3.900
  • 作者:
    Maria de Lourdes S Bastos;Brooke Finkmoore;Silvane Santos;Ohana Bispo;Tasso Barreto;Ingrid Cardoso;Iana Bispo;Flávia Bastos;Lee Riley;Edgar M Carvalho
  • 通讯作者:
    Edgar M Carvalho
HTLV-1 infection interferes with immune responses to Mycobacterium tuberculosis antigens
  • DOI:
    10.1186/1742-4690-12-s1-o24
  • 发表时间:
    2015-08-28
  • 期刊:
  • 影响因子:
    3.900
  • 作者:
    Natália B Carvalho;Maria de Lourdes Bastos;Yuri Neves;Anselmo Souza;Eduardo Martins Netto;Silvane Santos;Edgar M Carvalho
  • 通讯作者:
    Edgar M Carvalho

Edgar M Carvalho的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Edgar M Carvalho', 18)}}的其他基金

Administrative
行政的
  • 批准号:
    8501136
  • 财政年份:
    2013
  • 资助金额:
    $ 10.29万
  • 项目类别:
Immunological response, Viral Factors and Helminth Infections in Disease Expressi
疾病表现中的免疫反应、病毒因素和蠕虫感染
  • 批准号:
    8210351
  • 财政年份:
    2009
  • 资助金额:
    $ 10.29万
  • 项目类别:
Immunological response, Viral Factors and Helminth Infections in Disease Expressi
疾病表现中的免疫反应、病毒因素和蠕虫感染
  • 批准号:
    7509700
  • 财政年份:
    2009
  • 资助金额:
    $ 10.29万
  • 项目类别:
Immunological response, Viral Factors and Helminth Infections in Disease Expressi
疾病表现中的免疫反应、病毒因素和蠕虫感染
  • 批准号:
    7766918
  • 财政年份:
    2009
  • 资助金额:
    $ 10.29万
  • 项目类别:
Immunological response, Viral Factors and Helminth Infections in Disease Expressi
疾病表现中的免疫反应、病毒因素和蠕虫感染
  • 批准号:
    8025942
  • 财政年份:
    2009
  • 资助金额:
    $ 10.29万
  • 项目类别:
Administration of the UFBA/UFRN Tropical Medicine Research Center
UFBA/UFRN 热带医学研究中心的管理
  • 批准号:
    7513030
  • 财政年份:
    2007
  • 资助金额:
    $ 10.29万
  • 项目类别:
Protective and Pathogenic Immune Responses in Tegumentary Leishmania
外皮利什曼原虫的保护性和致病性免疫反应
  • 批准号:
    7284024
  • 财政年份:
    2007
  • 资助金额:
    $ 10.29万
  • 项目类别:
Protective and Pathogenic Immune Responses in Tegumentary Leishmania
外皮利什曼原虫的保护性和致病性免疫反应
  • 批准号:
    7513027
  • 财政年份:
    2007
  • 资助金额:
    $ 10.29万
  • 项目类别:
Administrative and Financial Core
行政和财务核心
  • 批准号:
    7284026
  • 财政年份:
    2007
  • 资助金额:
    $ 10.29万
  • 项目类别:
Immunological Response and Disease Expression in HTLV-1
HTLV-1 的免疫反应和疾病表达
  • 批准号:
    6809773
  • 财政年份:
    2005
  • 资助金额:
    $ 10.29万
  • 项目类别:

相似海外基金

Open Access Block Award 2024 - NHS Blood and Transplant NHSBT School
2024 年开放获取块奖 - NHS 血液和移植 NHSBT 学校
  • 批准号:
    EP/Z532551/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.29万
  • 项目类别:
    Research Grant
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
  • 批准号:
    MR/X032809/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.29万
  • 项目类别:
    Fellowship
A cluster randomized controlled trial to evaluate pharmacy-based health promotion program to improve blood pressure control in Bangladesh, India and Pakistan
一项整群随机对照试验,旨在评估孟加拉国、印度和巴基斯坦基于药房的健康促进计划,以改善血压控制
  • 批准号:
    23K24566
  • 财政年份:
    2024
  • 资助金额:
    $ 10.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
経胸壁心臓超音波のBlood Speckle Imagingを用いた大動脈弓部病変評価の研究
经胸心脏超声血斑成像评价主动脉弓病变的研究
  • 批准号:
    24K10591
  • 财政年份:
    2024
  • 资助金额:
    $ 10.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A methodology to connect functionalized gonadal constructs to a chick embryo through mechanically induced blood vessels from an egg
一种通过鸡蛋机械诱导血管将功能化性腺结构连接到鸡胚胎的方法
  • 批准号:
    24K15741
  • 财政年份:
    2024
  • 资助金额:
    $ 10.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
STTR Phase I: A Completely Non-Toxic Blood Bag That Keeps Blood Healthier, Longer
STTR 第一阶段:完全无毒的血袋,使血液保持更健康、更长久
  • 批准号:
    2335363
  • 财政年份:
    2024
  • 资助金额:
    $ 10.29万
  • 项目类别:
    Standard Grant
How blood vessel stiffness regulates their growth and maintenance
血管硬度如何调节其生长和维持
  • 批准号:
    DE240101055
  • 财政年份:
    2024
  • 资助金额:
    $ 10.29万
  • 项目类别:
    Discovery Early Career Researcher Award
Engaging the over 50s to ensure the sustainability of our blood supply
让 50 多岁的人参与进来,确保我们血液供应的可持续性
  • 批准号:
    LP220200819
  • 财政年份:
    2024
  • 资助金额:
    $ 10.29万
  • 项目类别:
    Linkage Projects
Defining a new mechanism of blood pressure regulation and its role during sepsis
定义血压调节的新机制及其在脓毒症期间的作用
  • 批准号:
    MR/Y011805/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.29万
  • 项目类别:
    Research Grant
Designing and fabricating artificial blood cells for global shortages
设计和制造人造血细胞应对全球短缺
  • 批准号:
    DE240100236
  • 财政年份:
    2024
  • 资助金额:
    $ 10.29万
  • 项目类别:
    Discovery Early Career Researcher Award
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了